Table 1.
Sample method | Population | Asthmatic subjects | Healthy controls (Ref) |
---|---|---|---|
Superior airway | |||
Nasopharyngeal aspirateS | Infants (0–12 months) n = 234 |
|
|
Nasal swabS |
Children and adolescents (6–20 years) n = 14 |
|
|
Nasal swabS |
Adults (35.8 +/− 16) n = 72 |
Increased Bacteroidetes (Prevotella), Proteobacteria (Alkanindiges), Actinobacteria (Gardnerella). | Less Proteobacteria and Bacteroidetes (Fazlollahi et al., 2018). |
Nasopharyngeal swabS |
Elderly (<60 years) n = 40 |
|
Higher relative abundance of Corynebacteriales (Lee et al., 2019). |
Oropharyngeal swabS | Elderly (53.4+/− 17.1//55 +/− 13) n = 47 | Proteobacteria (Pseudomonas s) and Firmicutes (Lactobacillus spp) are the most dominant populations in asthmatic subjects, these microorganisms not detected in healthy subjects. |
|
Hypopharyngeal aspirate C | Neonates (~1 month) n = 321 | Neonates colonized with Streptococcus pneumoniae, M. catarrhalis, Haemophilus influenzae showed increased asthma prevalence at 5 years. | Neonates not colonized with S. pneumoniae, M. catarrhalis or H. influenzae show less risk of a first wheezy episode (Bisgaard et al., 2007). |
Hypopharyngeal aspirateS | Children (12–36 months) n = 68 | Increase abundance of Moraxella, Haemophilus and Streptococcus, being Moraxella the predominant genera with mean relative abundance of 43.63%. | No healthy control was included (Thorsen et al., 2021). |
Broncho-alveolar lavage (BAL)S | Children (11.8 +/− 2.8 years) n = 20 | Increase Proteobacteria (Haemophilus) and Firmicutes (Streptococcus) in asthmatic children. | Increase Bacteroidetes (Prevotella) in healthy subjects (Hilty et al., 2010). |
Inferior airway | |||
Broncho-alveolar lavage (BAL)S | Children (11.8 +/− 2.8 years) n = 20 | Increase Proteobacteria (Haemophilus) and Firmicutes (Streptococcus) in asthmatic children. | Increase Bacteroidetes (Prevotella) in healthy subjects (Hilty et al., 2010). |
SputumS | Adults (39–62 years) n = 97 | Main species present in airway of healthy and asthmatics patients include Streptococcus Mitis, Streptococcus Aliviarus and Veillonella Dispar. | Airway microbiota similar to asthmatic patients. No differences in airway diversity between asthmatic patients and healthy controls in the composition of microbiota (Ham et al., 2021). |
Bronchial brushing S |
Adults (20–63 years) n = 40 |
|
Less abundant in Proteobacteria (Klebsiella) (Huang et al., 2015). |
Induced sputumS |
Adults (age 56–59) n = 167 |
|
No healthy control was included (Taylor et al., 2018). |
Gut | |||
Broncho-alveolar lavage (BAL)S | Children 11.8 +/− 2.8 years) n = 20 | Increase Proteobacteria (Haemophilus) and Firmicutes (Streptococcus) in asthmatic children. | Increase Bacteroidetes (Prevotella) in healthy subjects (Hilty et al., 2010). |
Fresh stoolS | Adults (18–50 years) n = 67 |
|
|
Fecal stoolS | Adults (39–62 years) n = 97 | At genus level, the leading bacteria are Prevotella, Bacteroides, Faecalibacterium, and Rominococcus. The most common species were Prevotella Copri, Faecalibacterium prausnitzii, and Bacteroides Plebeius. | Similar to asthmatic patients. There were no significant differences between groups or associations between gut microbiota composition and asthma (Ham et al., 2021). |
This table shows the microbial diversity in patients with asthma compared to other study groups, considering different life stages and respiratory/gut tract locations. Analysis Method. S: 16S rRNA gene sequencing. C: Culture. Ref.: Reference.